Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Over the last 12 months, insiders at Medpace Holdings, Inc. have bought $0 and sold $1.12B worth of Medpace Holdings, Inc. stock.
On average, over the past 5 years, insiders at Medpace Holdings, Inc. have bought $130.08M and sold $452.16M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 57,426 shares for transaction amount of $8.88M was made by Troendle August J. (CEO) on 2022‑09‑22.
2024-06-05 | Sale | BURWIG SUSAN E | Exec. VP, Operations | 7,681 0.0244% | $401.20 | $3.08M | -1.17% | |
2024-05-28 | Sale | Troendle August J. | CEO | 5,695 0.0186% | $395.49 | $2.25M | +2.39% | |
2024-05-24 | Sale | Troendle August J. | CEO | 3,987 0.013% | $395.22 | $1.58M | +2.14% | |
2024-05-22 | Sale | Troendle August J. | CEO | 55 0.0002% | $400.00 | $22,000 | +1.80% | |
2024-05-20 | Sale | Troendle August J. | CEO | 4,020 0.0131% | $400.19 | $1.61M | -0.25% | |
2024-05-16 | Sale | Troendle August J. | CEO | 7,060 0.0229% | $403.09 | $2.85M | +0.87% | |
2024-05-15 | Sale | Troendle August J. | CEO | 32,282 0.104% | $405.13 | $13.08M | -2.52% | |
2024-05-10 | Sale | Troendle August J. | CEO | 4,956 0.0165% | $402.89 | $2M | +1.51% | |
2024-05-09 | Sale | Troendle August J. | CEO | 3,486 0.0113% | $400.17 | $1.39M | -0.85% | |
2024-05-08 | Sale | Troendle August J. | CEO | 4,782 0.016% | $400.58 | $1.92M | +2.23% | |
2024-05-07 | Sale | Troendle August J. | CEO | 28,032 0.0913% | $404.48 | $11.34M | -1.53% | |
2024-05-06 | Sale | Troendle August J. | CEO | 24,372 0.0789% | $401.73 | $9.79M | -1.12% | |
2024-05-02 | Sale | Troendle August J. | CEO | 3,396 0.0112% | $400.44 | $1.36M | +1.33% | |
2024-05-01 | Sale | Troendle August J. | CEO | 12,934 0.0421% | $401.56 | $5.19M | -0.48% | |
2024-04-30 | Sale | Troendle August J. | CEO | 1,828 0.0061% | $400.31 | $731,767 | +2.04% | |
2024-04-29 | Sale | Troendle August J. | CEO | 15,102 0.0488% | $400.69 | $6.05M | -1.06% | |
2024-03-15 | Sale | BURWIG SUSAN E | Exec. VP, Operations | 102 0.0003% | $403.00 | $41,106 | -0.05% | |
2024-03-14 | Sale | Keating Ashley M. | director | 250 0.0008% | $409.87 | $102,468 | -1.97% | |
2024-03-08 | Sale | Troendle August J. | CEO | 25,000 0.0818% | $408.71 | $10.22M | -2.11% | |
2024-03-08 | Sale | Medpace Investors, LLC | 10 percent owner | 25,000 0.0818% | $408.71 | $10.22M | -2.11% |
Troendle August J. | CEO | 654656 18.2181% | $405.33 | 16 | 197 | +33.41% |
Medpace Investors, LLC | 10 percent owner | 4733019 18.2181% | $405.33 | 14 | 178 | +37.55% |
BURWIG SUSAN E | Exec. VP, Operations | 7500 0.0498% | $405.33 | 2 | 10 | +3.69% |
EWALD STEPHEN P | General Counsel & Corp. Secy. | 13341 0.0484% | $405.33 | 0 | 12 | |
GEIGER JESSE J | President | 3824 0.0208% | $405.33 | 0 | 16 | |
Brady Kevin M. | CFO & Treasurer | 6000 0.0196% | $405.33 | 0 | 4 | |
Kraft Robert O. | director | 188 0.0006% | $405.33 | 0 | 2 | |
Keating Ashley M. | director | 250 0% | $405.33 | 0 | 6 | |
DAVENPORT FRED B JR | director | 2000 0.0065% | $405.33 | 1 | 0 | +12.85% |
King Tom C | director | 598 0.0019% | $405.33 | 0 | 2 | |
Medpace Limited Partnership | 10 percent owner | 0 0% | $405.33 | 0 | 6 |
The Vanguard Group | $1.01B | 8.08 | 2.5M | -2.04% | -$21.07M | 0.02 | |
BlackRock | $1.01B | 8.05 | 2.49M | +3.1% | +$30.28M | 0.02 | |
Wasatch Advisors | $393.81M | 3.15 | 974,415 | -17.85% | -$85.59M | 2.06 | |
Invesco | $329.71M | 2.63 | 815,801 | +12.8% | +$37.41M | 0.07 | |
State Street | $281.68M | 2.25 | 696,959 | +3.85% | +$10.43M | 0.01 | |
Riverbridge Partners | $245.02M | 1.96 | 606,250 | -11.36% | -$31.4M | 3 | |
Td Asset Management Inc | $232.04M | 1.85 | 574,149 | +22.93% | +$43.29M | 0.2 | |
Geode Capital Management | $215.34M | 1.72 | 532,749 | +8.08% | +$16.09M | 0.02 | |
Goldman Sachs | $213.56M | 1.71 | 528,418 | +42.37% | +$63.56M | 0.04 | |
Epoch Investment Partners Inc | $164.27M | 1.31 | 406,446 | +15.32% | +$21.82M | 0.73 | |
Bessemer Group Inc | $159.57M | 1.27 | 394,834 | +1.58% | +$2.48M | 0.29 | |
Morgan Stanley | $154.13M | 1.23 | 381,366 | +10.22% | +$14.29M | 0.01 | |
American Capital Management, Inc. | $153.24M | 1.22 | 379,161 | -4.04% | -$6.45M | 4.91 | |
D. E. Shaw & Co. | $150.38M | 1.2 | 372,079 | +60.68% | +$56.79M | 0.2 | |
Renaissance Technologies | $129.65M | 1.04 | 320,788 | +27.61% | +$28.05M | 0.21 | |
Wellington Management Company | $128.48M | 1.03 | 317,903 | -23.32% | -$39.07M | 0.02 | |
Fuller & Thaler Asset Management, Inc. | $128.4M | 1.03 | 317,704 | -28.56% | -$51.34M | 0.56 | |
Dimensional Fund Advisors | $127.95M | 1.02 | 316,594 | -15.16% | -$22.87M | 0.04 | |
Boston Trust Walden Corp | $107.91M | 0.86 | 267,015 | -45.31% | -$89.42M | 0.77 | |
Los Angeles Capital Management LLC | $105.26M | 0.84 | 260,445 | +2.49% | +$2.55M | 0.36 | |
ClearBridge Investments | $105.25M | 0.84 | 260,411 | +302.41% | +$79.09M | 0.08 | |
T. Rowe Price | $103.5M | 0.83 | 256,100 | +1.27% | +$1.3M | 0.01 | |
Arrowstreet Capital, Limited Partnership | $101.44M | 0.81 | 250,998 | +29.31% | +$23M | 0.09 | |
Fidelity Investments | $94.1M | 0.75 | 232,833 | -3.3% | -$3.21M | 0.01 | |
Prudential Financial | $92.75M | 0.74 | 229,485 | +276.72% | +$68.13M | 0.13 | |
BNY Mellon | $90.99M | 0.73 | 225,140 | -8.2% | -$8.13M | 0.02 | |
Findlay Park Partners LLP | $90.25M | 0.72 | 223,300 | New | +$90.25M | 0.83 | |
Charles Schwab | $81.73M | 0.65 | 202,234 | -4.7% | -$4.03M | 0.02 | |
HERITAGE ASSET MANAGEMENT INC | $80.18M | 0.65 | 201,459 | -11.03% | -$9.94M | 0.41 | |
Royal Bank of Canada | $80.12M | 0.64 | 198,240 | -9.56% | -$8.47M | 0.02 | |
Northern Trust | $79.72M | 0.64 | 197,244 | -13.16% | -$12.08M | 0.01 | |
AQR Capital | $77.01M | 0.62 | 191,393 | -2.05% | -$1.61M | 0.13 | |
Giverny Capital Inc | $74.86M | 0.6 | 185,232 | +17.48% | +$11.14M | 3.04 | |
Jupiter Fund Management | $70.53M | 0.56 | 174,522 | -0.13% | -$90,933.75 | 0.19 | |
JPMorgan Chase | $70.19M | 0.56 | 173,685 | +8.61% | +$5.56M | 0.01 | |
GW&K Investment Management | $69.81M | 0.56 | 172,721 | -21.62% | -$19.26M | 0.62 | |
Voloridge Investment Management, LLC | $68.12M | 0.54 | 168,547 | +10.52% | +$6.48M | 0.15 | |
Loomis, Sayles & Company | $64.17M | 0.51 | 158,774 | -3.11% | -$2.06M | 0.09 | |
Franklin Templeton Investments | $62.82M | 0.5 | 155,443 | +345.46% | +$48.72M | 0.02 | |
Congress Asset Management Co Ma | $62.81M | 0.5 | 155,406 | +1.31% | +$813,149.80 | 0.45 | |
Two Sigma Advisers LP | $60.95M | 0.49 | 150,800 | -4.56% | -$2.91M | 0.1 | |
Bank of America | $58.09M | 0.46 | 143,728 | +5.64% | +$3.1M | 0.01 | |
Man Group Plc | $54.98M | 0.44 | 136,028 | -20.43% | -$14.11M | 0.14 | |
SEI Investments Company | $54.82M | 0.44 | 135,649 | +12.72% | +$6.19M | 0.08 | |
Millennium Management LLC | $54.73M | 0.44 | 135,432 | +97.15% | +$26.97M | 0.04 | |
First Trust | $51.62M | 0.41 | 127,731 | -20.15% | -$13.03M | 0.05 | |
Ameriprise Financial | $50.3M | 0.4 | 124,466 | -44.41% | -$40.19M | 0.01 | |
Rice Hall James & Associates, LLC | $49.26M | 0.39 | 121,885 | -4.51% | -$2.33M | 2.98 | |
Ranger Investment Management L P | $48.46M | 0.39 | 119,913 | -13.57% | -$7.61M | 3.18 | |
Fisher Asset Management Llc | $48.48M | 0.39 | 119,961 | -0.11% | -$55,368.55 | 0.02 |